Us2.ai Us2.ai
Platform Overview
Features
Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography
Operations
Operational Impact Deployment & Security Integrations Core Lab Solutions EHR Mining Partnerships
Tools
ROI Calculator Reimbursements Peer Comparison Regulatory Status
Library & news
Clinical Evidence Case Studies News
Our Story Careers Media Kit
Login Book a Demo
Login Book a Demo
Platform Overview
Features
Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography
Operations
Operational Impact Deployment & Security Integrations Core Lab Solutions EHR Mining Partnerships
Tools
ROI Calculator Reimbursements Peer Comparison Regulatory Status
Library & news
Clinical Evidence Case Studies News
Our Story Careers Media Kit
Back to News Nov 10, 2022

AI Echo digital health startup among the most promising startups in Southeast Asia

Us2.ai recognised among the most promising startups in SEA

Us2.ai

AI-powered echocardiography analysis. Fully automated, clinically validated, and trusted by leading institutions worldwide.

FDA Cleared
CE Marked
SOC 2 Type II
BSI Certified

Platform

Overview Integrations Use Cases Regulatory Status

Features

Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography

Operations

Operational Impact Deployment & Security Integrations Core Lab Solutions EHR Mining Partnerships

Resources

Tools

ROI Calculator Reimbursements Peer Comparison Regulatory Status Glossary

Library

Clinical Evidence Case Studies News

Company

Our Story Careers Media Kit Contact
© 2026 Us2.ai. All rights reserved. UEN 201723299R · UK ICO Reg. ZB661068 Trust Center · Report a Vulnerability · Privacy Policy · Terms of Service · Cookie Settings

We use essential cookies to ensure this site works properly. Privacy Policy